Lyell Immunopharma (LYEL)
(Delayed Data from NSDQ)
$1.18 USD
+0.09 (8.26%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $1.17 -0.01 (-0.85%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.20 |
EPS Last Quarter | -0.18 |
Last EPS Surprise | 10.00% |
ABR | 2.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.85 |
Next Year | -0.90 |
EPS (TTM) | -0.82 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.03M | 0.01M | 0.13M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.20 | -0.20 | -0.85 | -0.90 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | -0.18 | -0.18 | -0.78 | -0.85 |
High Estimate | -0.18 | -0.18 | -0.78 | -0.79 |
Low Estimate | -0.23 | -0.22 | -0.92 | -1.06 |
Year ago EPS | -0.20 | -0.20 | -0.93 | -0.85 |
Year over Year Growth Est. | 0.00% | 0.00% | 8.60% | -6.27% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.20 | -0.20 | -0.85 | -0.90 |
7 Days Ago | -0.20 | -0.20 | -0.85 | -0.90 |
30 Days Ago | -0.20 | -0.20 | -0.85 | -0.90 |
60 Days Ago | -0.21 | -0.20 | -0.86 | -0.92 |
90 Days Ago | -0.20 | -0.20 | -0.85 | -0.91 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.20 | -0.20 | -0.85 | -0.90 |
Zacks Consensus Estimate | -0.20 | -0.20 | -0.85 | -0.90 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.18 | -0.24 | -0.20 | -0.20 | NA |
Estimate | -0.20 | -0.20 | -0.21 | -0.27 | NA |
Difference | 0.02 | -0.04 | 0.01 | 0.07 | 0.02 |
Surprise | 10.00% | -20.00% | 4.76% | 25.93% | 5.17% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more